US$ 23.57
glutathione metabolism and its selective modification Implications for Health Glutathione - PMC
Description
Gerber et al., 2004

For reconstituted BPC-157: 28 days at 2-8C

By combining GLS1 inhibition (e.g., CB-839) and NQO1 -bioactivatable drugs (e.g., -lap, ARQ761), we exploit the reliance of PDA on glutamine for redox balance, as well as the tumor-selective overexpression of NQO1 through the use of a unique agent that is bioactivated to induce cell death

We love connecting with you and appreciate your enthusiasm
